Celltrion, Inc. Stock
Stocks
A068270
KR7068270008
Biotechnology & Medical Research
OTC Markets Traded|
End-of-day quote
Korea S.E.
12/08/2026
|
5-day change | 1st Jan Change | ||
| 202,000.00 KRW | -4.04% |
|
+6.15% | +17.18% |
| 04/08 | Celltrion Files Phase 3 Trial Amendment for CT-P44 Biosimilar for Myeloma | MT |
| 24/07 | Celltrion Submits EMA Marketing Authorization Application for Cosentyx Biosimilar CT-P55 | MT |
| Market Cap | 46,324B 32.7B 28.33B 26.54B 24.21B 45.51B 3,118B 46.21B 312B 122B 1,561B 123B 120B 5,207B | P/E 2026 * |
30.7x | P/E 2027 * | 26.5x |
|---|---|---|---|---|---|
| Enterprise Value | 48.3B 34.09M 29.54M 27.67M 25.24M 47.46M 3.25B 48.18M 325M 127M 1.63B 128M 125M 5.43B | EV / Sales 2026 * |
8.86x | EV / Sales 2027 * | 7.52x |
| Free-Float |
58.24% | Yield 2026 * |
0.38% | Yield 2027 * | 0.41% |
| 1 day | -4.04% | ||
| 1 week | +6.15% | ||
| Current month | +8.19% | ||
| 1 month | +15.30% | ||
| 3 months | +9.73% | ||
| 6 months | -11.07% | ||
| Current year | +17.18% |
| 1 week | 193,200 |  | 212,000 |
| 1 month | 168,200 | | 212,000 |
| Current year | 158,500 | | 239,047.62 |
| 1 year | 158,500 | | 239,047.62 |
| 3 years | 114,250.83 | | 239,047.62 |
| 5 years | 114,250.83 | | 247,058.06 |
| 10 years | 64,487.59 | | 325,235.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wu-Sung Ki
CEO | Chief Executive Officer | 65 | 20/03/2015 |
Jin-Seok Seo
CEO | Chief Executive Officer | 42 | 26/03/2021 |
Hyeok-Jae Lee
PSD | President | 50 | 13/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Jung-Jin Seo
CHM | Chairman | 68 | - |
Hyung-Ki Kim
BRD | Director/Board Member | 61 | 01/04/2005 |
Geun-Young Kim
BRD | Director/Board Member | 66 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/1/26 | Sell | 500 | 0.0002% | |||
| 16/1/26 | Sell | 1,000 | 0.0004% | |||
| 16/1/26 | Sell | 1,000 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.04% | +6.15% | +23.03% | +48.00% | 32.7B | |
| -1.60% | +0.86% | +3.70% | +14.41% | 48.72B | |
| -0.14% | +4.03% | +482.13% | +584.43% | 43.99B | |
| -0.06% | +9.62% | +24.63% | +81.63% | 40.82B | |
| -0.87% | +2.40% | +30.01% | +9.95% | 39.79B | |
| -1.41% | +1.57% | +29.98% | +123.68% | 16.66B | |
| +0.35% | +4.61% | - | - | 16.84B | |
| -0.43% | -0.11% | +4.22% | +20.83% | 13.95B | |
| +0.84% | +9.07% | +86.17% | +32.60% | 13.58B | |
| +0.96% | +2.24% | -1.13% | -35.30% | 12.9B | |
| Average | -0.64% | +3.79% | +75.86% | +97.80% | 27.99B | |
| Weighted average by Cap. | -0.90% | +3.85% | +99.04% | +129.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5,449B 3.85B 3.33B 3.12B 2.85B 5.35B 367B 5.44B 36.72B 14.35B 184B 14.44B 14.13B 612B | 6,325B 4.46B 3.87B 3.62B 3.31B 6.21B 426B 6.31B 42.62B 16.66B 213B 16.76B 16.4B 711B |
| Net income | 1,485B 1.05B 908M 851M 776M 1.46B 99.98B 1.48B 10.01B 3.91B 50.06B 3.94B 3.85B 167B | 1,768B 1.25B 1.08B 1.01B 924M 1.74B 119B 1.76B 11.92B 4.66B 59.6B 4.69B 4.58B 199B |
| Net Debt | 1,978B 1.4B 1.21B 1.13B 1.03B 1.94B 133B 1.97B 13.33B 5.21B 66.66B 5.24B 5.13B 222B | 1,262B 891M 772M 723M 660M 1.24B 84.99B 1.26B 8.51B 3.33B 42.55B 3.35B 3.27B 142B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/08/26 | KRW 202,000.00 | -4.04% | 926,438 |
| 11/08/26 | KRW 210,500.00 | +4.73% | 886,325 |
| 10/08/26 | KRW 201,000.00 | +0.85% | 533,999 |
| 07/08/26 | KRW 199,300.00 | +2.21% | 776,632 |
| 06/08/26 | KRW 195,000.00 | +2.47% | 801,664 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- A068270 Stock
Select your edition
All financial news and data tailored to specific country editions
